Skip to main content
Account

Peer review reports

From: ULTIMATE-SHF trial (UdenafiL Therapy to Improve symptoMAtology, exercise Tolerance and hEmodynamics in patients with chronic systolic heart failure): study protocol for a randomized, placebo-controlled, double-blind trial

Original Submission
24 Mar 2013 Submitted Original manuscript
29 May 2013 Reviewed Reviewer Report - Erik Cobo
3 Jun 2013 Author responded Author comments - Hyung-Kwan Kim
Resubmission - Version 2
3 Jun 2013 Submitted Manuscript version 2
Publishing
6 Jun 2013 Editorially accepted
22 Jun 2013 Article published 10.1186/1745-6215-14-188

Learn about peer review

Back to article page

Navigation